•  

    Fall 2026 Application

    Digital Innovations in 
    Immunology

  • Overview and Instructions

    Thank you for your interest in participating in PharmStars’ upcoming accelerator program. Please follow these guidelines:

    • Browser: We recommend using a Chrome browser to complete this application and disabling pop-up blockers to avoid issues when submitting the application.
    • Data: Do not include any confidential information, patient data, or links to patient data.
    • Drafts cannot be saved: This application cannot be saved as a draft. You may download a copy of the application here to work on the application offline.
    • Submission
      • Submission must be done online. Written copies are not accepted.
      • All mandatory fields, indicated with an asterisk, must be filled in to submit the application.
      • The application cannot be edited after submission.
      • A copy of your application will be sent to you upon successful submission.

    Applications must be submitted by 11:59 p.m. ET on July 12, 2026 to be considered.

     

  • Demographics

  • Will you be one of the two main participants representing your startup in the program?

  • Solution

  • 1. What is the status of your solution?*
  • 1b. When will your product be ready for market?*
     - -
  • 2. What is your solution? (check all that apply)*
  • 3. What type of technology do you have? (check all that apply)*

  • Maximum 1000 characters

  • Maximum 1000 characters

  • Maximum 1000 characters

  • Maximum 1000 characters

  • Maximum 1000 characters

  • 10. Are others (providers, payers) using your solution?*

  • Maximum 1000 characters

  • 14. Is your solution regulated?*

  • Company Details

  • 15. Have you raised funding for this company?*
  • 16. When will you be raising funds next?*
  • 17. Do you have revenues?*
  • 20. When was your company founded? *
     - -

  • Experience

  • 22. Is your startup currently negotiating or working with any pharma firms, or has your startup negotiated or worked with pharma in the past?*

  • Maximum 1000 characters

  • Rows
  • 22b. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Alexion?*
  • 22b-i. Please check all that apply and indicate the date of last engagement or contact with Alexion.*
  • 22c. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with AstraZeneca?*
  • 22c-i. Please check all that apply and indicate the date of last engagement or contact with AstraZeneca.*
  • 22d. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with CSL?*
  • 22d-i. Please check all that apply and indicate the date of last engagement or contact with CSL.*
  • 22e. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Genmab?*
  • 22e-i. Please check all that apply and indicate the date of last engagement or contact with Genmab.*
  • 22f. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Jazz?*
  • 22f-i. Please check all that apply and indicate the date of last engagement or contact with Jazz.*
  • 22g. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Novartis?*
  • 22g-i. Please check all that apply and indicate the date of last engagement or contact with Novartis.*
  • 22h. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Pfizer?*
  • 22h-i. Please check all that apply and indicate the date of last engagement or contact with Pfizer.*
  • 22j. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Sanofi?*
  • 22j-i. Please check all that apply and indicate the date of last engagement or contact with Sanofi.*
  • 22i. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Sumitomo?*
  • 22i-i. Please check all that apply and indicate the date of last engagement or contact with Sumitomo.*
  • 22j. Have you had any contact, introductory meetings, ongoing meetings, partnerships or deals with Takeda?*
  • 22j-i. Please check all that apply and indicate the date of last engagement or contact with Takeda.*

  • Maximum 1000 characters

  • Maximum 1000 characters

  • Accelerator Participation

  • Maximum 1000 characters

  • 24. Have you participated in any other accelerators?*

  • 25. Who will represent your company in PharmaU? (Please note: PharmStars expects participation by the CEO and at least one additional full-time senior-level executives with decision-making authority.)

    Representative 1 (required) - CEO:
             
                        
                     

  • Is the CEO full time with this company?*
  • Is the CEO involved with any other company?*

  • Representative 2 (required):
              
           
            

    Representative 3 (optional): 
              
           
                          

    Representative 4 (optional): 
                
                 
                                                                      

  • 26. Are all the people listed above full-time and permanent employees of your organization?*
  • 27. Are all the people listed above aware this application is being submitted and available to participate in PharmStars as described in the Accelerator Terms?*

  • 28.  You must be 18 years or older to participate in PharmStars. Please confirm both representatives are eligible to participate in the program:

  • 29. If selected, will both of the primary representatives of your startup attend the in-person launch event in Boston, MA on September 9-10, barring special circumstances that would prevent you from doing so (illness, travel restrictions, etc.)?*
  • 30. How did you hear about PharmStars?*
  • 31. Would you like to sign up for our newsletter to get practical tips on engaging with pharma and stay informed about upcoming PharmStars programs?

  • Additional Information

  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof

  • Maximum 1000 characters

  • The Submission Process

    Please confirm that you have read and will comply with the Accelerator Terms if selected to participate in PharmStars.  

  • Please review the following information and guidelines carefully:

    • Deadline:
      • Your application must be submitted by 11:59 p.m. ET on July 12 to be considered. 
    • Notifications:
      • Semi-finalists will be notified on a rolling basis and will have 3 business days to confirm their continued participation in the application process.
      • Accelerator acceptances will be emailed no later than August 26. Startups will have 2 business days to confirm their acceptance.
    • Launch Event:
      • PharmStars Fall cohort commences with a mandatory, in-person kickoff on September 9-10 in Boston, MA.
      • Please hold these dates to ensure attendance should your startup be selected to participate.
    • Class Schedule:
      • Classes meet virtually every Monday and Thursday from 12-1:30 p.m. ET, September 14 - November 5.
      • Please mark your calendar and ensure that you are available to attend all the twice-weekly classes.

  • Upon successful submission of your application:

    • Survey Page: You will be redirected to a survey page. If you are not redirected to the survey, please check your form for errors.
    • Email Confirmation: You should receive email confirmation of our receipt of your application within one hour. Please contact us at info@PharmStars.com if you do not receive a confirmation.
    • Copy of Your Submission: The confirmation email will include a copy of your submission. We highly recommend you save the PDF of your submission as you will need it as you advance through the process.

  • Thank you for applying to PharmStars!

  • Please contact info@PharmStars.com for questions.

  • Should be Empty: